{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:31:58Z","timestamp":1792661518607,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1053\/gast.2000.9561","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T17:58:00Z","timestamp":1122659880000},"page":"521-535","source":"Crossref","is-referenced-by-count":272,"title":["Nonsteroidal anti-inflammatory drug gastropathy"],"prefix":"10.1053","volume":"119","author":[{"given":"Christopher J.","family":"Hawkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/gast.2000.9561_bib1","first-page":"12","article-title":"History of aspirin and its mechanism of action","volume":"21","author":"Vane","year":"1990","journal-title":"Stroke"},{"key":"10.1053\/gast.2000.9561_bib2","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1053\/gast.2000.9561_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/newbio240200a0","article-title":"Prostaglandins, aspirin-like drugs and analgesia","volume":"240","author":"Ferreira","year":"1972","journal-title":"Nat New Biol"},{"key":"10.1053\/gast.2000.9561_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001574-199611000-00003","article-title":"Gastromucosal defense","volume":"12","author":"Wallace","year":"1996","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(00)78970-7","article-title":"Gastroscopic observation of the effect of aspirin and certain other substances on the stomach","volume":"2","author":"Douthwaite","year":"1938","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0002-9343(91)90118-H","article-title":"Non-steroidal anti-inflammatory drug\u2013associated gastropathy: incidence and risk factor models","volume":"61","author":"Fries","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/gast.2000.9561_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons","volume":"141","author":"Smalley","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1053\/gast.2000.9561_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365529209096006","article-title":"Gastric adaption to nonsteroidal anti-inflammatory drugs in man","volume":"27","author":"Olivero","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.1999.00489.x","article-title":"Expression of endothelial cell\u2013derived nitric oxide synthase (eNOS) is increased during gastric adaption to chronic aspirin intake in humans","volume":"13","author":"Fischer","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib10","first-page":"G830","article-title":"Indomethacin and turnover of gastric mucosal cells in the rat","volume":"250","author":"Baumgartner","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02208581","article-title":"Gastric mucosal adaptation to diclofenac injury","volume":"41","author":"Skeljo","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2000.9561_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjp.0701672","article-title":"Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastrointestinal ulcer models in rats","volume":"123","author":"Schmassmann","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.32.3.252","article-title":"Ranitidine in the treatment of non-steroidal anti-inflammatory drug\u2013associated gastric and duodenal ulcers","volume":"32","author":"Lancaster-Smith","year":"1991","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.34.6.748","article-title":"Effect of Helicobacter pylori colonization on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib15","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/S0002-9343(98)00276-9","article-title":"Nonsteroidal anti-inflammatory drug\u2013associated toxicity of the liver, lower gastrointestinal tract, and esophagus","volume":"105","author":"Bjorkman","year":"1998","journal-title":"Am J Med"},{"key":"10.1053\/gast.2000.9561_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00042737-199904000-00002","article-title":"NSAIDs and the oesophagus","volume":"11","author":"Mason","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/gast.2000.9561_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0016-5085(81)90196-7","article-title":"Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat","volume":"80","author":"Whittle","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","article-title":"Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs","volume":"327","author":"Allison","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/bmj.290.6465.347","article-title":"Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and hemorrhage","volume":"290","author":"Langman","year":"1985","journal-title":"Br Med J Clin Res"},{"key":"10.1053\/gast.2000.9561_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/gut.32.1.66","article-title":"Do non-steroidal anti-inflammatory drugs increase colonic permeability?","volume":"32","author":"Jenkins","year":"1991","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/gut.24.3.187","article-title":"Analgesic ingestion and other factors preceding relapse in ulcerative colitis","volume":"24","author":"Rampton","year":"1983","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib24","first-page":"2230","article-title":"Benign colonic ulcers associated with nonsteroidal anti-inflammatory drugs ingestion","volume":"89","author":"Stamm","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/bjs.1800780218","article-title":"Use of anti-inflammatory drugs and complicated diverticular disease: a case-control study","volume":"78","author":"Campbell","year":"1991","journal-title":"Br J Surg"},{"key":"10.1053\/gast.2000.9561_bib26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(94)90125-2","article-title":"A Simple, non-invasive marker of gastric damage: sucrose permeability","volume":"343","author":"Sutherland","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0016-5085(64)80125-6","article-title":"Gastric mucosal injury by fatty acid and acetylsalicylic acids","volume":"93","author":"Davenport","year":"1964","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1476-5381.1988.tb11733.x","article-title":"Induction of rat gastric damage by the endothelium-derived peptide, endothelin","volume":"95","author":"Whittle","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib29","first-page":"G601","article-title":"Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms","volume":"245","author":"Miller","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib30","first-page":"101","article-title":"Mechanisms of action of aspirin on the gastric mucosa of the guinea pig","volume":"103","author":"Garner","year":"1978","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1053\/gast.2000.9561_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.2042-7158.1971.tb08598.x","article-title":"Salicylates and enzymes","volume":"23","author":"Smith","year":"1971","journal-title":"J Pharm Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/00365517609054490","article-title":"Salicylate and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach","volume":"36","author":"Jorgensen","year":"1976","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1053\/gast.2000.9561_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gut.36.1.55","article-title":"Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?","volume":"36","author":"Roediger","year":"1995","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib35","first-page":"G42","article-title":"Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence","volume":"270","author":"Appleyard","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib36","first-page":"G993","article-title":"Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury","volume":"265","author":"Wallace","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0140-6736(90)92341-E","article-title":"Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer bleeding","volume":"336","author":"Levi","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000199424","article-title":"Cell proliferation of the rate gastrointestinal mucosa after treatment with E2 prostaglandins and indomethacin","volume":"36","author":"Uribe","year":"1987","journal-title":"Digestion"},{"key":"10.1053\/gast.2000.9561_bib39","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1023\/A:1018830408397","article-title":"Nonsteroidal anti-inflammatory drugs could reverse Helicobacter pylori\u2013induced apoptosis and proliferation in gastric epithelial cells","volume":"43","author":"Zhu","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2000.9561_bib40","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1023\/A:1018883102636","article-title":"Double-blind, placebo-controlled study on effects of diclofenac sodium and indomethacin on postprandial gastric motility in man","volume":"43","author":"Bassotti","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2000.9561_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01255603","article-title":"Upper gastroin-testinal disease in rheumatoid arthritis","volume":"19","author":"Sun","year":"1974","journal-title":"Dig Dis"},{"key":"10.1053\/gast.2000.9561_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00004836-199603000-00004","article-title":"Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs","volume":"22","author":"Day","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/cs0810565","article-title":"Separation of aspirin's impairment of hemostasis from mucosal injury in the human stomach","volume":"81","author":"Hawkey","year":"1991","journal-title":"Clin Sci"},{"key":"10.1053\/gast.2000.9561_bib44","first-page":"A97","article-title":"Interactions of risk factors for peptic ulcer bleeding","volume":"116","author":"Stack","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib45","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0002-9343(97)00211-8","article-title":"Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Schmassmann","year":"1998","journal-title":"Am J Med"},{"key":"10.1053\/gast.2000.9561_bib46","first-page":"G495","article-title":"Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense","volume":"277","author":"Podolsky","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-2362.1998.00330.x","article-title":"Adenine nucleotides modulate epithelial wound healing in vitro","volume":"28","author":"Dignass","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/gast.2000.9561_bib48","doi-asserted-by":"crossref","first-page":"C271","DOI":"10.1152\/ajpcell.1999.277.2.C271","article-title":"Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response","volume":"277","author":"Beltinger","year":"1999","journal-title":"Am J Physiol"},{"issue":"suppl 1","key":"10.1053\/gast.2000.9561_bib49","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00004836-199800001-00008","article-title":"Role of cyclooxygenase 2 in hepatocyte growth factor\u2013mediated gastric epithelial restitution","volume":"27","author":"Horie-Sakata","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib50","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1172\/JCI119723","article-title":"Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum","volume":"100","author":"Blikslager","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/gast.2000.9561_bib51","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/jn\/129.10.1791","article-title":"Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6","volume":"129","author":"Ruthig","year":"1999","journal-title":"J Nutr"},{"key":"10.1053\/gast.2000.9561_bib52","doi-asserted-by":"crossref","first-page":"C183","DOI":"10.1152\/ajpcell.1999.277.2.C183","article-title":"Myofibroblasts. II. Intestinal subepithelial myofibroblasts","volume":"277","author":"Powell","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/gast.2000.9561_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","article-title":"Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice","volume":"112","author":"Mizuno","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/gut.47.6.762","article-title":"Cyclooxygenase (COX)-1 and -2 in normal, inflamed and ulcerated human gastric mucosa","author":"Jackson","year":"2000","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.37.2.191","article-title":"Angiogenesis in gastric ulcers; impaired in patients taking non-steroidal anti-inflammatory drugs","volume":"37","author":"Hudson","year":"1995","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.45.4.529","article-title":"Expression of cyclooxygenase-1 and -2 by human gastric endothelial cells","volume":"45","author":"Hull","year":"1999","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib57","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing","volume":"5","author":"Jones","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/gast.2000.9561_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.300.6720.278","article-title":"Nonsteroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up?","volume":"300","author":"Hawkey","year":"1990","journal-title":"BMJ"},{"key":"10.1053\/gast.2000.9561_bib59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.2000.9561_bib60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib61","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.37.4.509","article-title":"Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin\u2013analysis of gastrointestinal bleeding during UK-TIA trial","volume":"37","author":"Slattery","year":"1995","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib63","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","article-title":"The ability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis","volume":"312","author":"Henry","year":"1996","journal-title":"BMJ"},{"key":"10.1053\/gast.2000.9561_bib64","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.46.1.27","article-title":"Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs","volume":"46","author":"Weil","year":"2000","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with non steroidal anti inflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D","article-title":"Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis","volume":"43","author":"Hawkey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/gast.2000.9561_bib68","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","article-title":"Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1053\/gast.2000.9561_bib69","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","article-title":"Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs","volume":"114","author":"Piper","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.2000.9561_bib70","first-page":"419","article-title":"Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study","volume":"7","author":"Hochain","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/gast.2000.9561_bib71","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/gut.32.7.730","article-title":"Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study","volume":"32","author":"Holvoet","year":"1991","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib72","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1532-5415.1982.tb01356.x","article-title":"Gastrointestinal consequences of treatment with drugs in elderly patients","volume":"30","author":"Johnson","year":"1982","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/gast.2000.9561_bib73","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/0016-5085(91)90661-4","article-title":"Age does not influence acute aspirin-induced gastric mucosal damage","volume":"100","author":"Moore","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0016-5085(92)70003-T","article-title":"Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans","volume":"102","author":"Cryer","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib75","first-page":"169","article-title":"A new ulcer model, \u201cunhealed gastric ulcers,\u201d induced by chronic treatment with indomethacin in rats with acetic acid ulcers","volume":"50","author":"Amagase","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib76","first-page":"395","article-title":"Review of dose-response studies of NSAIDs in rheumatoid arthritis","volume":"36","author":"Gotzsche","year":"1989","journal-title":"Dan Med Bull"},{"key":"10.1053\/gast.2000.9561_bib77","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJM199106133242407","article-title":"Nonsteroidal anti-inflammatory drugs-differences and similarities","volume":"324","author":"Brooks","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib78","first-page":"A192","article-title":"H. pylori infection increases the risk of non-steroidal anti-inflammatory drug (NSAID)-induced gastroduodenal ulceration","volume":"116","author":"Huang","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.41.4.459","article-title":"Peptic ulcer bleeding: relative roles of Helicobacter pylori and non-steroidal and anti-inflammatory drugs","volume":"41","author":"Cullen","year":"1997","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib80","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1023\/A:1018807412030","article-title":"Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study","volume":"42","author":"Pilotto","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2000.9561_bib81","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0016-5085(99)70494-4","article-title":"Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case control study","volume":"116","author":"Aalykke","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00365529950173618","article-title":"Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding","volume":"34","author":"Wu","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib83","first-page":"110","article-title":"Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study","volume":"31","author":"Labenz","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1053\/gast.2000.9561_bib84","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1365-2036.1999.00631.x","article-title":"Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users","volume":"13","author":"Santolaria","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib85","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/gut.39.1.22","article-title":"Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users. Response to omeprazole dual therapy","volume":"39","author":"Bianchi Porro","year":"1996","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib86","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pyloribefore non-steroidal anti-inflammatory drug therapy to prevent peptic ulcer","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib87","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Helicobacter pylori eradication in patients taking non-steroidal, anti-inflammatory drugs: The HELP NSAIDs Study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib88","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1365-2036.1998.00434.x","article-title":"Does eradication of Helicobacter pylori impair healing of non-steroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study","volume":"12","author":"Chan","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib89","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/S0016-5085(98)80353-3","article-title":"Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomized study","volume":"114","author":"Chan","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2036.2000.0701b.x","article-title":"Letter: response to Calvet and colleagues","volume":"14","author":"Hawkey","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.41.1.33","article-title":"Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer","volume":"41","author":"Labenz","year":"1997","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","article-title":"Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer","volume":"110","author":"Labenz","year":"1996","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1053\/gast.2000.9561_bib93","first-page":"A42","article-title":"Men are from Mars, women are from Venus: sex-related differences in ulcer disease expression and the influence of Helicobacter pylori","volume":"41","author":"Hawkey","year":"1994","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib94","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1073\/pnas.86.4.1178","article-title":"Identification of a phorbol ester-repressible v-src-inducible gene","volume":"86","author":"Simmons","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/gast.2000.9561_bib95","doi-asserted-by":"crossref","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","article-title":"The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes","volume":"265","author":"Fu","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1053\/gast.2000.9561_bib96","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/gast.2000.9561_bib97","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/gast.2000.9561_bib98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib99","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0092-8674(95)90126-4","article-title":"Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid\u2013induced inflammation and indomethacin-induced gastric ulceration","volume":"83","author":"Langenbach","year":"1995","journal-title":"Cell"},{"key":"10.1053\/gast.2000.9561_bib100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/378406a0","article-title":"Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II","volume":"378","author":"Dinchuk","year":"1995","journal-title":"Nature"},{"key":"10.1053\/gast.2000.9561_bib101","first-page":"735","article-title":"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids","volume":"289","author":"Catella-Lawson","year":"1999","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1053\/gast.2000.9561_bib102","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0009-9236(99)70056-1","article-title":"Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects","volume":"66","author":"Rossat","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib103","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.187.4.517","article-title":"Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells","volume":"187","author":"Kirtikara","year":"1998","journal-title":"J Exp Med"},{"key":"10.1053\/gast.2000.9561_bib104","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat Struct Biol"},{"key":"10.1053\/gast.2000.9561_bib105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3060247","article-title":"Effect of inhibitor time dependency on selectivity towards cyclooxygenase isoforms","volume":"306","author":"Ouellet","year":"1995","journal-title":"J Biochem"},{"key":"10.1053\/gast.2000.9561_bib106","first-page":"623","article-title":"Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs","volume":"48","author":"Patrignani","year":"1997","journal-title":"J Physiol Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib107","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","article-title":"Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors using sensitive microsomal and platelet essays","volume":"75","author":"Riendeau","year":"1997","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1053\/gast.2000.9561_bib108","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Non-steroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/gast.2000.9561_bib109","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-199958030-00016","article-title":"Rofecoxib","volume":"58","author":"Scott","year":"1999","journal-title":"Drugs"},{"key":"10.1053\/gast.2000.9561_bib110","first-page":"551","article-title":"Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/gast.2000.9561_bib112","first-page":"405","article-title":"Celecoxib: a COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis","volume":"34","author":"Boyce","year":"1999","journal-title":"Hosp Formulatory"},{"key":"10.1053\/gast.2000.9561_bib113","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin Ther"},{"key":"10.1053\/gast.2000.9561_bib114","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J","article-title":"Preliminary study of the safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects","volume":"41","author":"Simon","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/gast.2000.9561_bib115","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/gast.2000.9561_bib116","unstructured":"FDA celecoxib web site http:\/\/www.fda.gove\/cder\/foi\/label\/1998\/20998lbl.pdf"},{"key":"10.1053\/gast.2000.9561_bib117","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2036.1999.00529.x","article-title":"Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen","volume":"13","author":"Lanza","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib118","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0016-5085(99)70334-3","article-title":"A randomized trial comparing the effect of rofecoxib, a cyclooxygenase-2 specific inhibitor, with that or ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis","volume":"117","author":"Laine","year":"1999","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1053\/gast.2000.9561_bib119","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.282.20.1929","article-title":"Incidence of upper gastrointestinal perforations, symptomatic ulcers and bleeding (PUBS). Rofecoxib compared to NSAIDs","volume":"282","author":"Langman","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/gast.2000.9561_bib120","first-page":"A174","article-title":"Celecoxib is associated with a significantly lower incidence of clinically significant upper gastrointestinal (UGI) events in osteoarthritis (OS) and rheumatoid arthritis (RA) patients as compared to NSAIDs","volume":"116","author":"Goldstein","year":"1999","journal-title":"Gastroenterology"},{"issue":"suppl V","key":"10.1053\/gast.2000.9561_bib121","first-page":"30.03","article-title":"Evidence that the COX-2 specific inhibitor rofecoxib at 50 mg spares gastric mucosal prostaglandin synthesis in humans","volume":"45","author":"Wight","year":"1999","journal-title":"Gut"},{"key":"10.1053\/gast.2000.9561_bib122","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/gast.2000.9561_bib123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0016-5085(94)90074-4","article-title":"Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat","volume":"107","author":"Wallace","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(95)90341-0","article-title":"A nitric oxide-releasing non-steroidal anti-inflammatory drug accelerates gastric ulcer healing in rats","volume":"109","author":"Elliot","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib126","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0016-5085(95)90353-4","article-title":"Future treatments for arthritis\u2013new NSAIDs, NONSAIDs or no NSAIDs","volume":"109","author":"Hawkey","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib127","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.1997.115286000.x","article-title":"NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects","volume":"11","author":"Davies","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib128","first-page":"A107","article-title":"Nitric oxide donating flurbiprofen (HCT 1026) causes less endoscopic damage in healthy volunteers than flurbiprofen","volume":"114","author":"Donnelly","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm0295-154","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury","volume":"1","author":"Lichtenberger","year":"1995","journal-title":"Nat Med"},{"key":"10.1053\/gast.2000.9561_bib130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jps.2600830631","article-title":"Rationale for the development of stereochemically pure enantiomers: are the R enantiomers of chiral nonsteroidal anti-inflammatory drugs inactive?","volume":"83","author":"Wright","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1053\/gast.2000.9561_bib131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000171527","article-title":"Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists","volume":"1","author":"Koch","year":"1995","journal-title":"Dig Dis"},{"key":"10.1053\/gast.2000.9561_bib132","article-title":"Peptic ulcer disease: NSAID related. Evidence based gastroenterology","author":"Wight","year":"2000"},{"key":"10.1053\/gast.2000.9561_bib133","first-page":"223","article-title":"Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study","volume":"91","author":"Raskin","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib134","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/03009749209095074","article-title":"A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis","volume":"21","author":"Verdickt","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/gast.2000.9561_bib135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with arthritis receiving non steroidal anti-inflammatory drugs\u2013a randomized double blind placebo controlled study","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.2000.9561_bib136","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/gast.2000.9561_bib137","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2000.9561_bib138","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole and ranitidine for treating and preventing ulcers associated with non-steroidal anti-inflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib139","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/S0016-5085(98)80213-8","article-title":"Effectiveness of lansoprazole in the healing of NSAID-induced gastric ulcer in patients continuing to take NSAIDs","volume":"114","author":"Agrawal","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib140","first-page":"A295","article-title":"Evidence that lansoprazole is effective in preventing NSAID induced ulcers","volume":"116","author":"Rose","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2000.9561_bib141","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","article-title":"Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs","volume":"334","author":"Taha","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2000.9561_bib142","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archinte.1996.00440130066007","article-title":"Gastrointestinal tract complications of non-steroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study","volume":"156","author":"Singh","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/gast.2000.9561_bib143","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00001648-199905000-00006","article-title":"Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed","volume":"10","author":"Garcia Rodriguez","year":"1999","journal-title":"Epidemiology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850088823X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850088823X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T05:55:24Z","timestamp":1626242124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650850088823X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S001650850088823X"],"URL":"https:\/\/doi.org\/10.1053\/gast.2000.9561","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}